In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates

被引：8

作者：

Zaoutis, T

Moore, LS

Furness, K

Klein, JD

机构：

[1] Alfred I duPont Hosp Children, Div Pediat Infect Dis, Wilmington, DE 19899 USA

[2] Christiana Hosp, Christiana Care Hlth Syst, Infect Dis Lab, Newark, DE USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 07期

关键词：

D O I：

10.1128/AAC.45.7.1952-1954.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activities of meropenem, linezolid, quinupristin dalfopristin, vancomycin, and penicillin against 130 clinical isolates of group C and G streptococci, including vancomycin-tolerant isolates, were evaluated. Meropenem, linezolid, quinupristin-dalfopristin, vancomycin, and penicillin MICs at which 90% of the isolates were inhibited were 0.06, 2.0, 0.25, 0.5, and less than or equal to0.016 mug/ml, respectively. Meropenem, linezolid, quinupristin-dalfopristin, and penicillin were active against group C and G streptococci, including vancomycin-resistant strains.

引用

页码：1952 / 1954

页数：3

共 22 条

[1]

*AM AC PED, 1997, 1997 RED BOOK REP CO, P501

[2]

AUCKENTHALER R, 1983, REV INFECT DIS, V5, P196

[3]

BAYER AS, 1983, CLIN THER, V5, P391

[4] GROUP-C BETA-HEMOLYTIC STREPTOCOCCAL BACTEREMIA [J].

BERENGUER, J ;

SAMPEDRO, I ;

CERCENADO, E ;

BARAIA, J ;

RODRIGUEZCREIXEMS, M ;

BOUZA, E .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (02) :151-155

[5] In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin [J].

Bouanchaud, DH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :15-21

[6]

BRADLEY SF, 1991, REV INFECT DIS, V13, P270

[7] In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections [J].

Ford, CW ;

Hamel, JC ;

Wilson, DM ;

Moerman, JK ;

Stapert, D ;

Yancey, RJ ;

Hutchinson, DK ;

Barbachyn, MR ;

Brickner, SJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1508-1513

[8]

*NAT COMM CLIN LAB, 2001, METH DIL ANT SUSC TE, V20

[9]

*NAT COMM CLIN LAB, 1999, METH DET BACT ACT AN, V19

[10]

*NAT COMM CLIN LAB, 2001, PERF STAND ANT SUSC, V21

← 1 2 3 →